To explain the pro-tumorigenic merit of CCL5-overexpressing TAMs, we aimed to investigate the effects of intra-tumoral CCL5+ TAMs on the immune contexture of ccRCC. This evidence concerns the gene CCL5 and nonpapillary renal cell carcinoma.